Emergências e Terapia Intensiva
[Comunicado de imprensa – ainda não publicado] Em análise final, pílula da Pfizer contra Covid mantém a eficácia de 89% em reduzir o risco de internação ou morte.
15 Dez, 2021 | 12:47hComunicado de imprensa: Pfizer announces additional phase 2/3 study results confirming robust efficacy of novel Covid-19 oral antiviral treatment candidate in reducing risk of hospitalization or death
Comentários:
Pfizer’s Covid pill remains 89% effective in final analysis, company says – STAT
Pfizer confirms COVID pill’s results, potency versus omicron – Associated Press
Conteúdos relacionados:
8 lingering questions about the new Covid pills from Merck and Pfizer.
Comentário no Twitter (fio – clique para saber mais)
@pfizer releases more nirmatrelvir (#Paxlovid) data on #COVID19 final outcomes. Data are consistent, slightly better thant interim analysis. #IDTwitter
▪️ 88% overall hospitalization <=5days
▪️ No deaths in High Risk Trial (EPIC-HR)
▪️ Stopping drug 2.1%https://t.co/1D2LKan7tM— David Boulware, MD MPH (@boulware_dr) December 14, 2021
Posicionamento científico | Diagnóstico, tratamento e prevenção da ingestão de baterias na infância.
15 Dez, 2021 | 12:33hResumo visual: Diagnosis, Management, and Prevention of Button Battery Ingestion in Childhood
Comentário no Twitter (fio – clique para saber mais)
Button battery ingestion in children⚠️: Important🆕 guidelines for diagnosis and management from @ESPGHANSociety #GITwitter https://t.co/TQ1rfjQOpShttps://t.co/fxzzCEl2F2
— ESGE (@ESGE_news) December 14, 2021
Revisão | Diagnóstico e tratamento da apendicite aguda em adultos.
15 Dez, 2021 | 12:30hDiagnosis and Management of Acute Appendicitis in Adults: A Review – JAMA (gratuito por tempo limitado)
Entrevista com o autor: Current Management of Acute Appendicitis: Antibiotics or Surgical Intervention
Comentário: Antibiotics can be first-line therapy for uncomplicated appendicitis cases – Duke University Medical Center
Aprendizado sobre doenças infecciosas a partir de pacientes internados por tais doenças.
15 Dez, 2021 | 12:23hID Learning Units from Inpatient ID Consults – HIV and ID Observations
Podcast | Zero tensão para a hipertensão do paciente internado.
14 Dez, 2021 | 15:58h#310 No Tension About Inpatient Hypertension with Dr. Noble Maleque – The Curbsiders
COVID-19 e trombose: busca por evidências.
13 Dez, 2021 | 11:35hCOVID-19 and thrombosis: searching for evidence – Hematology, ASH Education Program
Como reconhecer e tratar a coagulopatia associada a COVID-19.
13 Dez, 2021 | 11:34hHow to recognize and manage COVID-19-associated coagulopathy – Hematology, ASH Education Program
M-A | Desempenho dos algoritmos 0/1-hora, 0/2-horas e 0/3-horas da European Society of Cardiology para triagem rápida de infarto agudo do miocárdio.
10 Dez, 2021 | 11:10hPerformance of the European Society of Cardiology 0/1-Hour, 0/2-Hour, and 0/3-Hour Algorithms for Rapid Triage of Acute Myocardial Infarction: An International Collaborative Meta-analysis – Annals of Internal Medicine (link para o resumo – $ para o texto completo)
Comentários:
Rapid ESC hs-cTn Algorithms Best 3-Hour Protocol for MI Rule-out: Meta-analysis – TCTMD
Performance of ESC 0/1-, 0/2-, 0/3-Hour Algorithms for AMI Compared – HealthDay
Comentário no Twitter
New meta-analysis published this week confirms new algorithms proposed by @escardio for ruling out #myocardialinfarction are more accurate than the previously preferred diagnostic tool: https://t.co/lAnozWXuOF pic.twitter.com/v2JGjyPRRW
— Annals of Int Med (@AnnalsofIM) November 25, 2021
M-A | Diltiazem vs. metoprolol intravenosos para fibrilação atrial com frequência ventricular rápida.
10 Dez, 2021 | 11:08hIntravenous diltiazem versus metoprolol for atrial fibrillation with rapid ventricular rate: A meta-analysis – The American Journal of Emergency Medicine (link para o resumo – $ para o texto completo)